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Hyperinsulinism: molecular aetiology of focal
disease
F Ryan, D Devaney, C Joyce, A Nestorowicz, M A Permutt, B Glaser, D E Barton,
P S Thornton

Abstract
Persistent hypoglycaemia in infancy is
most commonly caused by hyperinsulinism. A case is reported of the somatic loss
of the maternal 11p in an insulin secreting
focal adenoma in association with a germline SUR-1 mutation on the paternal allele
in a baby boy with hyperinsulinism diagnosed at 49 days old. A reduction to
homozygosity of an SUR-1 mutation is
proposed as a critical part of the cause of
focal hyperinsulinism.
(Arch Dis Child 1998;79:445–447)
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Persistent hypoglycaemia in infancy is most
commonly caused by hyperinsulinism. It is
characterised by profound hypoglycaemia
caused by inappropriate secretion of insulin.
Hyperinsulinism may be inherited in both
autosomal recessive1 and dominant2 forms. At
the molecular level, mutations in the sulphonylurea receptor (SUR-1)3 and the potassium
channel subunit (KIR6.2)4 have been identified in autosomal recessive forms of the
disease. Somatic loss of maternal chromosome
11p has been demonstrated in non-familial
cases with areas of focal adenomatosis5 and in
adenomas6 of the pancreas. In these reports,
the minimum region of chromosome 11p lost
included the SUR-1 and KIR6.2 genes, as well
as at least two maternally expressed imprinted
tumour suppresser genes (H19 and
P57KIP2).
We report the somatic loss of the maternal
11p in an insulin secreting focal adenoma in
association with a germline SUR-1 mutation
on the paternal allele in a patient with hyperinsulinism. We propose a reduction to homozygosity of an SUR-1 mutation as a critical part
of the cause of focal hyperinsulinism.
Case report
A baby boy, with no family history of hypoglycaemia, presented with hypoglycaemia on day
42 of life. Hyperinsulinism was diagnosed at 49
days based on the finding of increased glucose
requirement (15 mg/kg/min) to maintain euglycaemia. At a plasma glucose of 1.7 mmol/l
the patient’s insulin concentration was
297 pmol/l (normal < 14 pmol/l); at a plasma
glucose of 0.4 mmol/l, insulin was 75 pmol/l,
3-hydroxybutyrate
was
suppressed
at
0.02 mmol/l (normal > 1.5 mmol/l), and the
patient had a glycaemic response to glucagon
of > 1.7 mmol/l. Diazoxide and octreotide

treatment was unsuccessful and surgery was
performed on day 84.
At surgery an adenoma was palpated and
partial pancreatectomy (approximately 40%)
performed. Histology confirmed an insulin
staining adenoma with normal pancreatic
tissue in the surrounding area. The patient
recovered well, tolerated a 13 hour fasting
interval at age 4 months, and has had no
subsequent hypoglycaemia.
Genomic DNA was extracted from patient
and parental peripheral blood leucocytes, and
from patient paraYn embedded tissue using
standard techniques. SUR-1 exon 10 sequences
were amplified using standard polymerase chain
reaction (PCR) conditions (GibcoBRL; Life
Technologies, Paisley, UK) using exon 10 primers SUR-10F (5'–GTGGAGACGACCCGCA
GGAAGGAG–3') and SUR-10R (5'–CCTT
GCATGTACGCAGCAGCACCC–3'). Equal
quantities of PCR product was digested for at
least two hours with Bsr1 using conditions as
described by the manufacturer. Bsr1 digestion
of wild-type product yields two fragments of 66
and 50 base pairs. The mutated allele remains
uncut. For GATA23FO6 and TH7 microsatellite analysis, PCR was performed as above and
analysed on a 7% Long Ranger gel run on a
Pharmacia ALF automatic sequencing system
(Pharmacia BioFech, St Albans, UK).
Results
Patient leucocyte DNA was screened for 24
previously identified SUR-1 mutations8 and 2
KIR6.2 mutations; heterozygosity for an SUR
1 intron 10 splice site mutation (1630+1
G→T) was discovered. This mutation had
previously been identified in three other
patients with hyperinsulinism. One was a
compound heterozygote for this and another
SUR-1 mutation, whereas in the other two the
mutation was identified on the paternal allele
with no mutation identified on the maternal
allele. As this mutation destroys a Bsr1 restriction site, enzyme digestion of exon 10 PCR
product was used to identify the mutation in
patient and parental samples (fig 1), demonstrating that the mutation was paternally
derived. Analysis of DNA from the patient’s
normal pancreatic tissue demonstrated a
heterozygous pattern of normal and mutant
allele. In contrast, DNA extracted from
adenoma tissue contained mostly mutant
allele.
To investigate if this was the result of loss of
the maternal allele we performed microsatellite
analysis
using
11p
specific
markers
GATA23FO6 and TH. TH lies approximately
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Figure 1 Mutation detection in patient and parental DNA samples. Agarose gel showing
products of BsrI restriction of SUR exon 10 sequences. The figure shows homozygous
wild-type pattern for the maternal DNA, heterozygous (1630+1 G→T) mutation in the
paternal, patient leucocyte and normal pancreatic tissue, but reduction to almost complete
homozygous 1603+1G→T mutation in patient adenoma. PBL, peripheral blood leucocytes;
T, tail of pancreas (normal); B, body of pancreas (normal); A, adenoma; M, 100 base pair
marker.

30 centimorgans telomeric to the SUR-1 gene
with the GATA23FO6 between the TH and
SUR-1. The results demonstrated a Mendelian inheritance pattern in the patient’s leucocyte and normal pancreatic tissue, and a loss of
the maternal 11p in the adenoma (fig 2). Our
results indicate that the hyperinsulinism in this
case is as a result of a reduction to homozygosity of the SUR-1 mutation in the adenoma tissue.

Discussion
de Lonlay and colleagues5 demonstrated loss of
heterozygosity (LOH) in focal hyperplasia of
the pancreas. They proposed that the hyperplasia was either caused by a loss of the imprinted
tumour suppresser genes H19 or P57KIP2, or
an expression imbalance between H19 and
IGF II. Their studies explain the hyperplasia in
focal disease but do not adequately address the
hypersecretion of insulin in the focal tissue.
Beckwith-Wiedemann syndrome, a condition
in which 20% have LOH of chromosome 11p
(the region containing the SUR-1 locus) is
associated with hyperinsulinism in 30% of
cases, but the occurrence of hyperinsulinism in
these patients does not correlate with the
occurrence of the LOH.7 We propose a model
where the somatic loss of the maternal 11p is
the causative factor for focal hyperplasia but
that the hyperplasia itself is not suYcient to
cause insulin hypersecretion. With the additional presence of a paternally derived SUR-1
mutation, there is a reduction to homozygosity
for SUR-1 in focal cells resulting in dysregulation of insulin secretion and ultimately to the
hyperinsulinism phenotype. Resection of the
aVected tissue resulted in a cure in a similar
fashion to the partial pancreatectomy performed by de Lonlay et al in focal hyperplasia,
unlike autosomal recessive hyperinsulinism in
which a 95% pancreatectomy is often insuYcient. In conclusion, this case demonstrates a
novel mechanism for the apparent sporadic
inheritance of disease considered an autosomal
recessive disorder.

Figure 2 Microsatellite analysis of patient and parental DNA samples. ALF trace of (A) TH and (B) GATA23F06
microsatellite analysis. Lanes 4 and 13, size marker; lanes 5, 6, 7, and 13, 14, 15, peripheral blood leucocyte DNA from
patient, mother, and father respectively; lanes 9, 10, and 18, 20, DNA from normal and adenoma tissue respectively. A
Mendelian inheritance pattern is seen in normal tissue and almost complete loss of the maternal allele is seen in adenoma
tissue. PCR products were identified by electrophoresis on a Pharmacia ALF. Open squares indicate PCR products, closed
circles are internal size marker; open circles are external size marker.
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Acute scrotal swelling
Beware the facts that everybody knows. Everybody knows, for instance,
and paediatric textbooks confirm, that epididymitis is rare in children.
Several case series, however, have suggested that this may not be true.
In Salt Lake City, USA 64 of 90 boys with acute scrotal pain or
swelling had epididymitis and 50 of the 64 were under 12 years old
(Howard A Kadish and Robert G Bolte. Pediatrics 1998;102:73–6). Of
the remaining 26, 13 had testicular torsion (TT) and 13 torsion of the
appendix testis (TAT). Fewer of those with epididymitis presented
within 12 hours of symptom onset and they were more likely than those
with torsion to have fever, a history of previous similar pain, or dysuria, although each of these features was present in fewer than 20% of
boys with epididymitis. The testicular lie was normal in all boys with
epididymitis or TAT but abnormal in almost half of those with TT. The
testis as a whole was tender in all those with TT, 69% of those with
epididymitis, and 31% of those with TAT, but all boys with TAT had
localised tenderness at the superior pole of the testis. The cremasteric
reflex was absent in all patients with TT, 14% with epididymitis, and
none with TAT. Scrotal erythema or oedema was more common in
epididymitis (67%) than in TT (38%) or TAT (8%, one patient). Coloured Doppler ultrasound showed decreased blood flow in all seven
patients with TT in whom it was performed, one of 29 with
epididymitis, and neither of two with TAT. Ten of the 13 boys with TT
had salvageable testes.
None of this should lead clinicians into delaying surgery for boys
who might have testicular torsion. In Salt Lake City they operate right
away if the diagnosis is at all likely and do Doppler studies only when
there is serious doubt.
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